CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (unaudited) (USD $)	6 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash flows from operating activities:
Net loss	$ (11,832,388)	$ (3,953,787)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	42,825	197,081
Fair value of vested options issued to officers, directors and employees	873,023	1,174,778
Change in fair value of warrant liability	6,852,518
Amortization of capitalized financing costs		85,975
Amortization of debt discount attributable to convertible debentures		541,120
Equity based compensation	13,238	58,238
Common stock issued in settlement of interest		507,939
Change in operating assets and liabilities:
Increase in accounts receivable	(110,803)	(115,056)
Decrease in prepaid expenses and deposits	54,762	39,954
Increase (decrease) in accounts payable and accrued liabilities	217,714	(379,829)
Net cash used in operating activities	(3,889,111)	(1,843,587)
Cash flows from investing activities:
Purchase of property and equipment	(30,061)	(47,133)
Net cash used in investing activities	(30,061)	(47,133)
Cash flows from financing activities:
Net proceeds from sale of common stock	2,000,000
Proceeds from sale of Series A preferred stock	5,500,000
Proceeds from exercise of warrants	150,000
Purchase and cancelation of previously issued warrants	(50,000)
Net cash provided by financing activities	7,600,000
Net increase (decrease) in cash and cash equivalents	3,680,828	(1,890,720)
Cash and cash equivalents at beginning of period	724,782	2,747,294
Cash and cash equivalents at end of period	4,405,610	856,574
Supplemental Disclosures of Cash Flow Information:
Cash paid during period for interest
Cash paid during period for taxes
Non-cash investing and financing activities:
Common stock issued in exchange for previously incurred debt		$ 4,022,000